Nadine Buckland: I knew I’d make a better business owner than employee April 9, 2026 Each week, we dig into the memory bank of the City's great and good. Today, Nadine Buckland, CEO of Zenzic Capital, takes us through her business career.
Sumitomo Corporation, SMBC Aviation Capital, Apollo and Brookfield Complete the Acquisition of Air Lease Corporation April 8, 2026 Sumitomo Corporation, SMBC Aviation Capital, Apollo-managed funds (“Apollo”) and Brookfield today announced that they have completed the previously announced acquisition of Air Lease Corporation (“Air Lease”) and have renamed the business Sumisho Air Lease Corporation (“Sumisho Air Lease”). This transformational transaction improves the financial position of the business with long term support and aviation expertise [...]
Experian UK&I strengthens its leading digital verification capabilities with the addition of Konfir April 8, 2026 Joining forces enhances Experian’s employment and income verification at scale, improving speed and quality of customer journeys
Jet fuel crisis sparks rush for travel insurance as airlines warn of Summer cancellations April 7, 2026 Interest in travel insurance has spiked over the last month after airline bosses warned of cancelled flights amid shortages of jet fuel due to the ongoing energy crisis. Thousands of flights have been cancelled, and more cuts are planned, as global airlines struggle with surging fuel costs and supply issues caused by the war in [...]
Goldman Sachs flagship private credit fund bucks industry sell-off April 7, 2026 Goldman Sachs’ flagship private credit fund has said investors looked to pull less than five per cent of their holdings in the first three months of this year, dodging an industry-wide redemptions wave that has forced some rivals to gate their funds. The investment bank’s direct lending arm, which functions like a private equity fund [...]
Jamie Dimon eyes high interest rates, uneven lending and IPO dearth in JP Morgan shareholder letter April 6, 2026 One of the biggest names in global banking issued a stark warning about global political uncertainty and the potential threat of higher asset prices on Monday, while pointing to the faltering pipeline for company flotations. Jamie Dimon, the chief executive of JPMorgan Chase, added his voice to a debate raging in world financial centres on [...]
On this day: The death of JP Morgan March 31, 2026 Today in 1913, John Pierpoint Morgan died in Rome having saved the United States from financial catastrophe not once but twice, writes Eliot Wilson Today in 1913, in Rome’s Grand Plaza Hotel, a 75-year-old American died in his sleep. He was a big man, 6’2” and heavyset, with sharp, unsettling eyes and a purple, swollen [...]
For FSCS sake: Meet the body that protects Britain’s savers in a financial crisis March 30, 2026 As echoes of 2008 percolate through the banking system, the body that serves to protect Britain in a financial crisis says it’s ready to weather any storm. A combination of fears around private credit, the “stretched” value of artificial intelligence firms and more recently, concerns around a global energy shock, have made top bankers sound [...]
Claire Williams on missing out on $2bn, state of F1 and MP ambitions March 25, 2026 Six years ago, in August of 2020, Claire Williams sold her eponymous Formula 1 racing team – founded by her father in 1977 – for around $150m to US investment group Dorilton Capital. The deal cleared the team’s debts amid financial difficulties and the Covid-19 pandemic, and ensured the team would race on – keeping [...]
Compass Pathways Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Highlights March 24, 2026 COMP360 is the first classic psychedelic1 to consistently achieve a highly statistically significant result and clinically meaningful effect in treatment resistant depression (TRD), with a generally well-tolerated and safe profile Across three large trials in TRD, including two positive Phase 3 studies, COMP360’s differentiated profile is redefining rapidity and durability for TRD patients and demonstrating a consistent level of clinical effect that has never been achieved before Compass will meet with the FDA to confirm alignment on a rolling submission and review, and expects to complete the NDA submission in Q4 Compass is rapidly advancing commercial readiness plans and expects COMP360 will fit seamlessly across diverse healthcare settings at launch Phase 2b/3 trial in PTSD initiating, following FDA acceptance of IND application Successful $150 million financing in February and exercise of $200 million in warrants extends cash runway into 2028